ACON ACLARION INC
ACLARION INC (ACON) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $1.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.1% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About ACLARION INC
Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA.
Sector
Healthcare
Industry
Healthcare Info Services